REVOFIL AQUASHINE PTX – 2 Pre-Filled Syr…

INFORMATION

Revofil Aquashine PTX is a hyaluronic acid-based dermal filler combined with bioactive peptides designed for skin rejuvenation and anti-aging effects. The product is aimed at improving skin elasticity, hydration, and reducing wrinkles. The inclusion of peptides provides additional benefits for collagen production and skin revitalization, making this filler ideal for individuals seeking both aesthetic and regenerative skin improvements.

Revofil Aquashine PTX comes in two pre-filled syringes of 2 ml each and contains non-crosslinked hyaluronic acid along with peptides, amino acids, vitamins, and minerals.

Revofil Aquashine PTX Indications for Use

Revofil Aquashine PTX is indicated for:

Skin rejuvenation and hydration in areas showing signs of aging.
Treatment of fine lines and wrinkles, especially in the face, neck, and décolletage areas.
Improving skin elasticity and texture by enhancing collagen synthesis.
Skin brightening, evening out skin tone, and reducing pigmentation.

Target Areas:

Forehead, nasolabial folds, marionette lines, and crow’s feet.
Cheeks, chin, and jawline for volume and contour enhancement.
Neck and hands for skin revitalization.
Revofil Aquashine PTX Dosage Information
Each treatment session involves the use of 2 ml of product from a pre-filled syringe.
Revofil Aquashine PTX should be injected into the superficial to mid-dermis, depending on the treatment area and the severity of wrinkles.
Recommended treatment cycle: A series of 3-4 sessions spaced 4 weeks apart for optimal results.
Maintenance treatments can be performed every 6-12 months, depending on patient needs.

Injection depth:

For fine lines: Inject into the superficial dermis.
For moderate wrinkles: Inject into the mid-dermis.

Needle size: 30G or 27G depending on the area being treated.

Revofil Aquashine PTX Side Effects and Precautions

Revofil Aquashine PTX is generally well-tolerated, with few side effects. However, some patients may experience common reactions typical of dermal filler injections, including:

Redness, swelling, and bruising at the injection site.
Mild discomfort or itching, which usually resolves within a few days.

Serious complications are rare but may include:

Infection, asymmetry, or granuloma formation.
Temporary swelling or hypersensitivity reactions in patients prone to allergies.

Precautions:

Not suitable for patients with severe allergies, especially those allergic to hyaluronic acid or peptides.
Avoid use in pregnant or breastfeeding women.
Patients with autoimmune disorders or undergoing immunosuppressive therapy should consult a doctor before treatment.
Injections should not be performed in areas with active inflammation, acne, or infections.
Revofil Aquashine PTX Clinical Studies and Outcomes

Revofil Aquashine PTX has demonstrated significant improvements in skin hydration, elasticity, and wrinkle reduction. Patients undergoing clinical trials reported visible improvements in skin tone and texture, with long-lasting results after a series of treatments.

Key Findings:

90% reduction in hyaluronidase activity, leading to prolonged hyaluronic acid presence in the skin.
81% increase in collagen production, significantly enhancing skin firmness.
45% increase in hyaluronic acid levels, contributing to improved hydration and skin plumpness.

Patient Satisfaction: Over 99% of patients reported satisfaction after a series of treatments, with visible reductions in wrinkles and an overall improvement in skin tone and texture. Results typically last for up to 12 months before a maintenance session is needed.

Clinical Case Example: A patient in her 40s, treated with Revofil Aquashine PTX for nasolabial folds and fine lines, showed visible improvements after 3 treatment sessions spaced 4 weeks apart. Her skin became more plump, and the wrinkles were significantly diminished after 6 months.

Revofil Aquashine PTX Drug Interactions

There are no significant drug interactions specific to Revofil Aquashine PTX. However, caution should be exercised for patients on blood thinners or anticoagulants as these may increase the likelihood of bruising or bleeding at the injection site.

Patients using medications that affect collagen metabolism or skin structure should consult their physician before undergoing treatment.

Revofil Aquashine PTX Application Instructions

The injection procedure should be carried out by a trained medical professional under sterile conditions to prevent infections and complications.

Procedure:

Prepare the treatment area by thoroughly disinfecting it.
Inject Revofil Aquashine PTX using a 30G or 27G needle into the superficial or mid-dermis based on the severity of the wrinkles.
Massage the treated area gently after the injection to ensure even distribution of the filler.
Aftercare includes applying cold compresses to reduce swelling and advising the patient to avoid sun exposure or heat for the next 24-48 hours.
Revofil Aquashine PTX Storage and Handling

Revofil Aquashine PTX should be stored at room temperature between 2°C to 25°C. The product should be kept away from direct sunlight and freezing conditions. Once opened, the syringe should not be reused to prevent contamination or infection.